News and Resources > News
COMMENT ON A DRUG PRODUCT
The CCAC is pleased to see INESSS inviting patient and patient group input when evaluating drugs for reimbursement in Quebec. The patient perspective is an important one and what patients value in their treatment journey should be taken into consideration when deliberating on the reimbursement of a medication.
The CCAC would like to hear from Quebec-based patients/caregivers on INESSS’ efforts to incorporate the patient perspective into the drug approval process.
Incorporating the patient perspective into the drug approval process aligns well with the CCAC’s Patient Values Project which aims to provide more objective and quantifiable-based input into the patient group submissions we make when a cancer drug is under review. Let us know what you think.
Email us at: email@example.com
or call us at: 514-875-7745